Artemis Global Life Sciences Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
-
|
P/BV
|
-
|
Book Value (Rs.)
|
-
|
52 Week High/Low (Rs.)
|
-
|
FV/ML
|
-
|
P/E(X)
|
-
|
Bookclosure
|
-
|
EPS (Rs.)
|
-
|
Div Yield (%)
|
-
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 |
| | | |
Net Profit/Loss Before Extraordinary Items And Tax | 36.74 | 34.90 | 32.56 |
| | | |
Net CashFlow From Operating Activities | 40.45 | 71.38 | 52.29 |
Net Cash Used In Investing Activities | -49.52 | -66.57 | -70.21 |
Net Cash Used From Financing Activities | 14.37 | -9.67 | 21.72 |
| | | |
Net Inc/Dec In Cash And Cash Equivalents | 5.30 | -4.86 | 3.80 |
Cash And Cash Equivalents Begin of Year | 3.94 | 8.80 | 5.00 |
Cash And Cash Equivalents End Of Year | 9.24 | 3.94 | 8.80 |